Nephron’s Simpson on Durable Medical Equipment Pay Rule; CGMs

Nephron Research’s Health Policy team of Paul Heldman and Sasha Simpson have been incredibly active since joining in July of this year.  In a great example of the value they add to Nephron clients’ investment process, Sasha Simpson has been in print twice over the last week on the potential for changes from CMS related to durable medical equipment (DME) and more specifically addressing Medicare reimbursement risk to continuous glucose monitors (CGMs) via an upcoming payment rule.  Digging deep into the mechanics, cadence, and ultimately handicapping the potential impact of any changes, Nephron’s Health Policy team is working hard to separate useful analyses from market noise. for more info.